Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q3 EPS of ($0.75), $0.06 better than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.